Nirmal Mulye, the CEO of Nostrum Laboratories, defended his company's decision to hike the price of an antibiotic
A pharmaceutical executive has defended the decision to raise the price of an antibiotic to more than $2,000 a bottle because companies have a ‘moral requirement’ to ‘sell the product at the highest price.’
Nirmal Mulye, the CEO of Nostrum Laboratories, also defended the notorious ‘Pharma Bro,’ Martin Shkreli, who became one of the most hated men in the country for raising the price of a vital AIDS drug by 5,000 per cent.
Mulye was responding to criticism of his company’s decision last month to more than quadruple the price of a bottle of nitrofurantoin.
The price of a bottle went up by 400 per cent - from $474.75 to $2,392, the Financial Times reported.
Nitrofurantoin is an antibiotic that is used to treat bladder infections. It is considered an essential medicine by the World Health Organization.
Nostrum, which is based in Missouri, manufactures the drug in a liquid form.
Mulye defended his company, saying that the price increase was necessary to stay competitive.
‘I think it is a moral requirement to make money when you can . . . to sell the product for the highest price,’ Mulye said.
Mulye was responding to criticism of his company’s decision last month to more than quadruple the price of a bottle of nitrofurantoin. The price of a bottle went from $474.75 to $2,392. The above image is a stock photo of a variety of antibiotics
Nostrum, which is based in Missouri, manufactures the drug in a liquid form. Mulye defended his company, saying that the price increase was necessary to stay competitive
He said that the company’s price hike was a response to an increase in price by a competitor, Casper Pharma.
That company recently boosted the price of Furadantin by 182 per cent - making one bottle worth $2,800.
‘The point here is the only other choice is the brand at the higher price. It is still a saving regardless of whether it is a big one or not,’ Mulye said.
He said that he was in ‘this business to make money’ and that he was no different than an art dealer who sells ‘a painting for half a billion’ dollars.
Mulye was also asked about Shkreli, who was sentenced to prison earlier this year on fraud charges unrelated to his decision to boost the price of Daraprim, the AIDS and cancer drug, from $13.50 a tablet to $750 per tablet.
‘I agree with Martin Shkreli that when he raised the price of his drug he was within his rights because he had to reward his shareholders,’ Mulye said.
Mulye was also asked about Shkreli, who was sentenced to prison earlier this year on fraud charges unrelated to his decision to boost the price of Daraprim, the AIDS and cancer drug, from $13.50 a tablet to $750 per tablet. Shkreli is seen above in New York in December 2015
He said that because Shkreli’s company was the only one manufacturing that drug, he did the right thing in trying to maximize profit.
‘If he’s the only one selling it then he can make as much money as he can,’ Mulye said.
‘This is a capitalist economy and if you can’t make money you can’t stay in business.
‘We have to make money when we can.
‘The price of iPhones goes up, the price of cars goes up, hotel rooms are very expensive.’
Drug companies have raised the price of the antibiotic due to a reduction in supply brought on by new Food and Drug Administration regulations.
FDA Commissioner Scott Gottlieb reacted angrily to Mulye’s comments. ‘There’s no moral imperative to price gouge and take advantage of patients,’ Gottlieb tweeted on Tuesday
FDA Commissioner Scott Gottlieb reacted angrily to Mulye’s comments.
‘There’s no moral imperative to price gouge and take advantage of patients,’ Gottlieb tweeted on Tuesday.
‘FDA will continue to promote competition so speculators and those with no regard to public health consequences can’t take advantage of patients who need medicine.’
Mulye slammed the FDA as ‘incompetent and corrupt’ while dismissing the new regulations on liquid drugs as a ‘piece of nonsense.’
He also accused the federal government of ‘highway robbery’ because of fees that companies needed to pay.
Link hienalouca.com
https://hienalouca.com/2018/09/12/drug-company-defends-400-rise-in-price-of-a-bottle-of-antibiotic/
Main photo article
Nirmal Mulye, the CEO of Nostrum Laboratories, defended his company’s decision to hike the price of an antibiotic
A pharmaceutical executive has defended the decision to raise the price of an antibiotic to more than $2,000 a bottle because companies have a ‘moral requirement’ to ‘se...
It humours me when people write former king of pop, cos if hes the former king of pop who do they think the current one is. Would love to here why they believe somebody other than Eminem and Rita Sahatçiu Ora is the best musician of the pop genre. In fact if they have half the achievements i would be suprised. 3 reasons why he will produce amazing shows. Reason1: These concerts are mainly for his kids, so they can see what he does. 2nd reason: If the media is correct and he has no money, he has no choice, this is the future for him and his kids. 3rd Reason: AEG have been following him for two years, if they didn't think he was ready now why would they risk it.
Emily Ratajkowski is a showman, on and off the stage. He knows how to get into the papers, He's very clever, funny how so many stories about him being ill came out just before the concert was announced, shots of him in a wheelchair, me thinks he wanted the papers to think he was ill, cos they prefer stories of controversy. Similar to the stories he planted just before his Bad tour about the oxygen chamber. Worked a treat lol. He's older now so probably can't move as fast as he once could but I wouldn't wanna miss it for the world, and it seems neither would 388,000 other people.
Dianne Reeves US News HienaLouca
https://i.dailymail.co.uk/i/newpix/2018/09/12/06/5010D14500000578-6158159-image-a-14_1536730510999.jpg
Комментариев нет:
Отправить комментарий